amlodipine and Hyperpotassemia studies

amlodipine and Hyperpotassemia

amlodipine has been researched along with Hyperpotassemia in 2 studies

Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.

Research Excerpts

Excerpt	Relevance	Reference
"Hyperkalemia was associated with increased risk of combined cardiovascular disease (hazard ratio, 1."	2.77	Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. ( Alderman, MH; Calhoun, DA; Cushman, WC; Davis, BR; Eckfeldt, JH; Einhorn, PT; Ford, CE; Franklin, SS; Furberg, CD; Ong, ST; Oparil, S; Papademetriou, V; Piller, LB; Probstfield, JL, 2012)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

1 (50.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Alderman, MH	1
Piller, LB	1
Ford, CE	1
Probstfield, JL	1
Oparil, S	1
Cushman, WC	1
Einhorn, PT	1
Franklin, SS	1
Papademetriou, V	1
Ong, ST	1
Eckfeldt, JH	1
Furberg, CD	1
Calhoun, DA	1
Davis, BR	1
Erickson, CP	1

Studies

Alderman, MH

Piller, LB

Ford, CE

Probstfield, JL

Oparil, S

Cushman, WC

Einhorn, PT

Franklin, SS

Papademetriou, V

Ong, ST

Eckfeldt, JH

Furberg, CD

Calhoun, DA

Davis, BR

Erickson, CP

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
[NCT00000542]	Phase 3	0 participants	Interventional	1993-08-31	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

[NCT00000542]

Phase 3

0 participants

Interventional

1993-08-31

Completed

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for amlodipine and Hyperpotassemia

Article	Year
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:5 Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Chemical Analysis; Cardiovascular Diseases; Chlorth	2012

Article

Year

Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.

Hypertension (Dallas, Tex. : 1979), 2012, Volume: 59, Issue:5

Topics: Aged; Amlodipine; Antihypertensive Agents; Blood Chemical Analysis; Cardiovascular Diseases; Chlorth

2012

Other Studies

1 other study available for amlodipine and Hyperpotassemia

Article	Year
Case 24-2006: a woman with hypotension after an overdose of amlodipine. The New England journal of medicine, 2006, Nov-02, Volume: 355, Issue:18 Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Cardiac Glycosides; Contraindications; Human	2006

Article

Year

Case 24-2006: a woman with hypotension after an overdose of amlodipine.

The New England journal of medicine, 2006, Nov-02, Volume: 355, Issue:18

Topics: Amlodipine; Animals; Calcium; Calcium Channel Blockers; Cardiac Glycosides; Contraindications; Human

2006